Wealth Advisory Solutions’s Gilead Sciences GILD Stock Holding History

Wealth Advisory Solutions’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$267K	Buy	2,117 +541	+34%	+$71.3K	0.05%	123
2026 Q1	$220K	Sell	1,576 -132	-8%	-$18.5K	0.05%	132
2025 Q4	$210K	Buy	+1,708	New	+$208K	0.05%	135
2022 Q3	–	Sell	-3,252	Closed	-$201K	–	139
2022 Q2	$201K	Buy	+3,252	New	+$201K	0.05%	141
2020 Q3	–	Sell	-2,847	Closed	-$219K	–	182
2020 Q2	$219K	Sell	2,847 -857	-23%	-$65.7K	0.06%	167
2020 Q1	$276K	Buy	3,704 +291	+9%	+$20.1K	0.09%	135
2019 Q4	$221K	Buy	+3,413	New	+$222K	0.06%	168

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wealth Advisory Solutions's GILD Position: Q2 2026 in Review

Wealth Advisory Solutions increased its Gilead Sciences (GILD) stake by 34% in Q2 2026, buying an estimated $71.3K and bringing the position to 2,117 shares worth $267K. The position accounts for 0.05% of the portfolio, ranked #123.

Wealth Advisory Solutions first reported a position in GILD in Q4 2019 and has held it in 7 quarters since. The position peaked at $276K in Q1 2020. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Wealth Advisory Solutions held 2,117 shares of Gilead Sciences worth $267K as of Q2 2026.
Wealth Advisory Solutions bought 541 Gilead Sciences shares in Q2 2026, an estimated $71.3K.
Gilead Sciences made up 0.05% of Wealth Advisory Solutions's portfolio in Q2 2026, its #123 holding.
Wealth Advisory Solutions first reported a position in Gilead Sciences in Q4 2019 and has held it in 7 quarters since.
Wealth Advisory Solutions's Gilead Sciences position peaked at $276K in Q1 2020.
2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Wealth Advisory Solutions's 13F filing for Q2 2026, filed 24 Jul 2026.